Vaccines are the key technology to combat existing and emerging infectious diseases.
However, increasing the potency, quality and durability of the vaccine response remains a …

Cancer vaccination is an effective way to prevent or cure cancers by inducing strong cellular
and humoral immunity with the aid of delivery carriers or adjuvants. Increasing new delivery …

Vaccination against COVID-19 is one of the critical tools to provide herd immunity, reduce
mortality, and control the pandemic worldwide. Despite the safety of vaccination against …

Inflammation plays a critical role in the response to and survival from injuries and/or
infections. It occurs in two phases: initiation and resolution; however, when these events do …

A degraded/dysfunctional immune system appears to be the main determinant of
serious/fatal reaction to viral infection (for COVID-19, SARS, and influenza alike). There are …

Research over the past several decades has provided insight into the mode of action of
adjuvants. However, the main focus of attention has been the efficacy in the induction of …

The existence of pathogens that escape recognition by specific vaccines, the need to
improve existing vaccines and the increased availability of therapeutic (non-infectious …

Cancer immunotherapy, such as the Toll-like receptor (TLR) agonist including CpG
oligodeoxynucleotide, has shown potency in clinical settings. However, it is still confronted …

Although naturally occurring, self-assembled protein nanoarchitectures have been utilized
as antigen-delivery carriers, and the inability of such carriers to elicit immunogenicity …

Autoimmune and other chronic inflammatory diseases (AID) are prevalent diseases which
can severely impact the quality of life of those that suffer from the disease. In most cases, the …